Background The pandemic of the coronavirus disease 2019 (COVID-19) has brought a
global public health crisis. However, the pathogenesis underlying COVID-19 are barely …

Objective The mortality rate for critically ill COVID-19 cases was more than 80%.
Nonetheless, research about the effect of common respiratory diseases on critically ill …

The COVID-19 pandemic has emerged as a global health emergency due to its association
with severe pneumonia and relative high mortality. However, the molecular characteristics …

The molecular pathology of lung injury in patients with Corona Virus Disease 2019 (COVID-
19) remain unclear. In this study, we performed a proteomic study of lung tissues from seven …

Up to 10–20% of patients with coronavirus disease 2019 (COVID‐19) develop a severe
pulmonary disease due to immune dysfunction and cytokine dysregulation. However, the …

COVID-19 is the most impacting global pandemic of all time, with over 600 million infected
and 6.5 million deaths worldwide, in addition to an unprecedented economic impact …

Despite the understanding of the coronavirus disease-19 (COVID-19), the role of salivary
extracellular vesicles (sEVs) in COVID-19 remains unclear. Exploring the proteomic cargo of …

Introduction The outbreak of the newly discovered human coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has disrupted the normal life of almost …

Serum or plasma have been the primary focus of proteomics studies for COVID-19 to identity
biomarkers and potential drug targets. The nasal mucosal environment which consists of …

Background Information on the microbiome's human pathways and active members that can
affect SARS-CoV-2 susceptibility and pathogenesis in the salivary proteome is very scarce …